Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast

Clinical Rheumatology

Volumn 24, Issue 6, 2005, Pages 661-662

  Shimbo, Junsuke ^a   Onodera, Osamu ^a   Tanaka, Keiko ^a   Tsuji, Shoji ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Churg Strauss syndrome; Leukotriene receptor antagonists; Pranlukast

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; PRANLUKAST; PREDNISOLONE;

ARTICLE; ASTHMA; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG RESPONSE; DRUG WITHDRAWAL; EOSINOPHIL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MENTAL DEFICIENCY; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHROMONES; CHURG-STRAUSS SYNDROME; HUMANS; LEUKOTRIENE ANTAGONISTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 27844555495     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1035-z     Document Type: Article

References (15)

1. Franco J, Artes MJ (1999) Pulmonary eosinophilia associated with montelukast. Thorax 54:558-560 1:STN:280:DyaK1MzgvFWmtw%3D%3D
2. Kinoshita M, Shiraishi T, Koga T et al (1999) Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast. J Allergy Clin Immunol 103:534-535 1:STN:280:DyaK1M7mvFWmsQ%3D%3D
3. Wechsler ME, Garpestad E, Flier SR et al (1998) Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 279:455-457 10.1001/ jama.279.6.455
4. Wechsler ME, Finn D, Gunawardena D et al (2000) Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 117:708-713 10.1378/chest.117.3.708
5. Green RL, Vayonis AG (1999) Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet 353:725-726 10.1016/S0140-6736(99)00565-6
6. Baba K, Niwa S, Yagi T et al (2000) Churg-Strauss syndrome during corticosteroid tapering in a patient with bronchial asthma receiving pranlukast. Arerugi 49:512-515 1:CAS:528:DC%2BD3MXkslKkt7g%3D
7. Hayashi S, Furuya S, Imamura H (2001) Fulminant eosinophilic endomyocarditis in an asthmatic patient treated with pranlukast after corticosteroid withdrawal. Heart 86:E7 10.1136/heart.86.3.e7
8. Hashimoto M, Fujishima T, Tanaka H et al (2001) Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma. Intern Med 40:432-434 1:STN:280:DC%2BD3MzhvVOjsg%3D%3D
9. Shigeto K, Shyugo I, Naoto T et al (2003) Churg-Strauss syndrome (CSS) in a patient receiving pranlukast. Clin Rheumatol 22:491-492 10.1007/ s10067-003-0791-5
10. Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094-1100 1:STN:280:By%2BA2MfovFY%3D
11. Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671-678 1:STN:280:ByqC38%2Fks1Q%3D
12. Guillevin L, Lhote F, Gayraud M et al (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: A prospective study in 342 patients. Medicine (Baltimore) 75:17-28 10.1097/ 00005792-199601000-00003
13. van Swieten JC, Koudstaal PJ, Visser MC et al (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607 3363593
14. Drazen JM, Israel E, O'Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197-206 10.1056/ NEJM199901213400306
15. Lewis RA, Austen KF, Soberman RJ et al (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323:645-655 1:CAS:528:DyaK3MXktVCruw%3D%3D